Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Cidara Therapeutics (20D0.F) Q3 2024 Earnings
20D0.F
13
Aug
Confirmed
Q2 2024
Q3 2024
-18.18
-12.82
-7.45
-2.09
Details
Expected EPS
-3.7280889999999998
Actual EPS
-18.176707099999998
Surprise EPS
-14.45
Surprise Percent
+387.56%
Description
Cidara Therapeutics (20D0.F) has reported earnings of -18.176707099999998 per share for Q3 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login